Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Seung-Jung Park50,000 enrolled

Overview

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Study Type

OBSERVATIONAL

Enrollment

50,000

Conditions

Coronary Artery Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several drug eluting stents * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock

Locations (1)

Asan Medical Center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Major Adverse Cardiac Event

Death from any causes, myocardial infarction or any repeat revascularization

Time frame: 1year

Secondary Outcomes

all cause Death

Time frame: 1year

Myocardial Infarction

Time frame: 1year

The composite of Death or myocardial infarction

Time frame: 1year

Any repeat revascularization

Time frame: 1year

Target vessel revascularization

Time frame: 1year

Target lesion revascularization

Time frame: 1year

New lesion revascularization

Time frame: 1year

Stent thrombosis by Academic Research Consortium criteria

Time frame: 1year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.